Clinical Report: Continuous Engagement in Ocular Care

Overview

This report highlights the critical need for continuous patient engagement in managing chronic ocular conditions, particularly contact lens retention and dry eye disease. It emphasizes that significant clinical changes often occur between scheduled visits, leading to gaps in patient care and safety.

Background

Chronic ocular conditions, such as dry eye disease and contact lens discomfort, are prevalent and often underreported by patients. Traditional care models rely on infrequent consultations, which fail to capture the dynamic nature of these conditions. This gap in monitoring can lead to delayed treatment and worsening symptoms, underscoring the need for a more proactive approach in eye care.

Data Highlights

No numerical data available in the source material.

Key Findings

• One in four new contact lens wearers drop out within the first year due to discomfort and visual problems.
• Dry eye disease is a chronic, multifactorial condition that can lead to corneal damage and vision loss.
• Current care models do not adequately address the fluctuations in symptoms that occur between patient visits.
• Continuous patient engagement can improve monitoring and management of ocular conditions, reducing unnecessary appointments.
• Emerging therapies, such as perfluorohexyloctane, show promise in managing dry eye symptoms effectively.

Clinical Implications

Healthcare providers should consider implementing continuous monitoring systems to track patient symptoms between visits. This approach can facilitate timely interventions and improve patient outcomes in chronic ocular conditions.

Conclusion

Adopting a model of continuous engagement in eye care can bridge the gap between patient visits, enhancing the management of chronic conditions and ultimately improving patient safety and satisfaction.

Related Resources & Content

1. Eyecare Business, Eyecare Business, 2011 -- Marketing: Marrying Social Media with Email
2. Eyecare Business, Eyecare Business, 2020 -- The Wild, Wild Web
3. Optometric Management, Optometric Management, 2025 -- How Strategic Social Engagement Drives Practice Growth
4. Contact Lens Spectrum, Contact Lens Spectrum, 2006 -- Contact Lens Economics
5. TFOS DEWS III: Executive Summary - ScienceDirect, ScienceDirect, 2025 -- TFOS DEWS III: Executive Summary
6. Efficacy and safety of perfluorohexyloctane (PFHO) in patients with dry eye disease (DED) due to meibomian gland dysfunction (MGD): Systematic review and meta-analysis - PMC, PMC, 2025 -- Efficacy and safety of PFHO
7. TFOS DEWS III: Executive Summary - ScienceDirect
8. Efficacy and safety of perfluorohexyloctane (PFHO) in patients with dry eye disease (DED) due to meibomian gland dysfunction (MGD): Systematic review and meta-analysis - PMC